Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism

被引：0
|
作者：
Schulman, S. [1 ]
Eriksson, H. [2 ]
Goldhaber, S. Z. [3 ]
Kakkar, A. K. L. [4 ,5 ]
Kearon, C. [6 ]
Kvamme, A. M. [7 ]
Mismetti, P. [8 ]
Schellong, S. [9 ]
Schnee, J. [10 ]
机构：
[1] HHS Gen Hosp, Thrombosis Serv, Hamilton, ON, Canada
[2] Sahlgrenska Univ Hosp Oestra, Dept Med, Gothenburg, Sweden
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
[4] Thrombosis Res Inst, London SW3 6LR, England
[5] Queen Mary Univ London, London, England
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] Boehringer Ingelheim GmbH & Co KG, Dept Med, Oslo, Norway
[8] Bellevue Hosp, Dept Vasc Pathol, St Etienne, France
[9] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany
[10] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O-TH-033
引用
收藏
页码：731 / 732
页数：2
相关论文
共 50 条
  • [41] Warfarin initiation nomograms for venous thromboembolism
    Garcia, Pedro
    Ruiz, Wilson
    Munarriz, Cesar Loza
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (07):
  • [42] Warfarin initiation nomograms for venous thromboembolism
    Garcia, Pedro
    Ruiz, Wilson
    Munarriz, Cesar Loza
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [43] Secondary prophylaxis with warfarin for venous thromboembolism
    Buller, HR
    Prins, MH
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07): : 702 - 704
  • [44] Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism
    Paik, Julia
    PEDIATRIC DRUGS, 2022, 24 (04) : 423 - 431
  • [45] Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials
    Tomkowski, Witold
    Kuca, Pawel
    Bignamini, Angelo A.
    Andreozzi, Giseppe M.
    INTERNATIONAL ANGIOLOGY, 2017, 36 (05) : 496 - 497
  • [46] Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
    Fang, Margaret C.
    Reynolds, Kristi
    Fan, Dongjie
    Prasad, Priya A.
    Sung, Sue Hee
    Portugal, Cecilia
    Garcia, Elisha
    Go, Alan S.
    JAMA NETWORK OPEN, 2023, 6 (08) : e2328033
  • [47] Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis
    Diken, Adem I.
    Yalcinkaya, Adnan
    Hanedan, Muhammet O.
    Erol, Mehmet E.
    Diken, Ozlem Ercen
    PHLEBOLOGY, 2018, 33 (01) : 53 - 59
  • [48] Real-World Risk of Thromboembolism or Bleeding with Warfarin or Dabigatran Therapy in Patients with Atrial Fibrillation
    Charland, Scott I.
    Malone, Daniel C.
    Agatep, Barnabie C.
    Herrera, Vivian
    Hawk, Gosia S.
    Schrader, Bruce J.
    Stanek, Eric J.
    CIRCULATION, 2012, 126 (21)
  • [49] Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
    Kang, Hye-Rim
    Jones, Bobby L.
    Lo-Ciganic, Wei-Hsuan
    DeRemer, Christina E.
    Dietrich, Eric A.
    Huang, Pei-Lin
    Park, Haesuk
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (03)
  • [50] THE COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE COMPARED WITH WARFARIN IN THE TREATMENT AND SECONDARY PREVENTION OF ACUTE VENOUS THROMBOEMBOLISM IN THE UK
    Jugrin, A., V
    Ustyugova, A., V
    Urbich, M.
    Lamotte, M.
    Sunderland, T. J.
    VALUE IN HEALTH, 2014, 17 (07) : A489 - A489
12345